Case Report
Published on 30 Oct 2024
Primary seminal vesicle diffuse large B-cell lymphoma: a case report and review of the literatures
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1461090
- 653 views
Type at least 3 characters
6,669 articles
Articles
Mini Review
Published on 30 Oct 2024
A single-cell perspective on immunotherapy for pancreatic cancer: from microenvironment analysis to therapeutic strategy innovation
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1454833
- 584 views
Review
Published on 30 Oct 2024
Oncolytic virus and CAR-T cell therapy in solid tumors
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1455163
- 751 views
Original Research
Accepted on 29 Oct 2024
Single-cell transcriptomics reveals heterogeneity and prognostic markers of myeloid precursor cells in acute myeloid leukemia
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1494106
Original Research
Accepted on 29 Oct 2024
Anti-PD1 therapies induce an early expansion of Ki67 + CD8 + T cells in metastatic non-oncogene addicted NSCLC patients
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1483182
Review
Accepted on 28 Oct 2024
Neuroimaging in the primary and metastatic brain tumors treated with immunotherapy: Current status, imaging advances, and artificial intelligence
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1496627
Original Research
Published on 28 Oct 2024
Single-cell and bulk transcriptomic datasets enable the development of prognostic models based on dynamic changes in the tumor immune microenvironment in patients with hepatocellular carcinoma and portal vein tumor thrombus
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1414121
- 999 views
Case Report
Published on 28 Oct 2024
Case report: MSI-H, EGFR mutation, and ground-glass nodules as diffuse pulmonary hematogenous metastases
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1478205
- 406 views
Review
Published on 28 Oct 2024
Extracellular vesicles in hepatocellular carcinoma: unraveling immunological mechanisms for enhanced diagnosis and overcoming drug resistance
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1485628
- 531 views
Original Research
Published on 28 Oct 2024
Computational staining of CD3/CD20 positive lymphocytes in human tissues with experimental confirmation in a genetically engineered mouse model
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1451261
- 578 views
Case Report
Published on 28 Oct 2024
Case report: Significant response of alpha-fetoprotein-producing gastric cancer from combined chemotherapy and immunotherapy
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1448875
- 394 views
Original Research
Published on 28 Oct 2024
Hypofractionated radiotherapy with simultaneous integrated boost for localized prostate cancer patients: effects on immune system and prediction of toxicity
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1457839
- 483 views
Original Research
Published on 28 Oct 2024
Cuproptosis-related lncRNAs emerge as a novel signature for predicting prognosis in prostate carcinoma and functional experimental validation
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1471198
- 439 views
Review
Published on 28 Oct 2024
Companion diagnostics and predictive biomarkers for PD-1/PD-L1 immune checkpoint inhibitors therapy in malignant melanoma
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1454720
- 703 views
Review
Accepted on 25 Oct 2024
Gut Microbiota as a Biomarker and Modulator of Anti-tumor Immunotherapy Outcomes
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1471273
Original Research
Published on 25 Oct 2024
High-resolution subtyping of fibroblasts in gastric cancer reveals diversity among fibroblast subsets and an association between the MFAP5-fibroblast subset and immunotherapy
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1446613
- 781 views